IL6 and chronic myelogenous leukemia, BCR-ABL1 positive: Preclinical studies showed that PML upregulation in mesenchymal stromal cells upregulated inflammatory cytokines (IL-6/IL-6R and CXCL1/CXCR2), which are crucial for the maintenance in the BMM and TKI-resistance of CML stem cells [146].